Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
OTCMKTS
· Delayed Price · Currency is USD
1.945
+0.045 (2.37%)
At close: Mar 27, 2025
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,557 employees as of December 31, 2024. The number of employees increased by 187 or 0.46% compared to the previous year.
Employees
40,557
Change (1Y)
187
Growth (1Y)
0.46%
Revenue / Employee
$138,727
Profits / Employee
$9,357
Market Cap
8.04B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Northwest Biotherapeutics | 25 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Shanghai Fosun Pharmaceutical (Group) News
- 4 weeks ago - Shanghai Fosun Pharmaceutical reports FY results - Seeking Alpha
- 1 year ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 2 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 3 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 4 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 4 years ago - Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse - Seeking Alpha
- 4 years ago - Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal - Seeking Alpha
- 4 years ago - Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations - CNBC